Format

Send to

Choose Destination
NDT Plus. 2009 Nov;2(Suppl_3):iii12-iii19.

Current and future treatment options in SIADH.

Author information

1
Department of Internal Medicine, Erasmus Medical Center, Rotterdam , The Netherlands.

Abstract

The treatment of hyponatraemia due to SIADH is not always as straightforward as it seems. Although acute treatment with hypertonic saline and chronic treatment with fluid restriction are well established, both approaches have severe limitations. These limitations are not readily overcome by addition of furosemide, demeclocycline, lithium or urea to the therapy. In theory, vasopressin-receptor antagonists would provide a more effective method to treat hyponatraemia, by virtue of their ability to selectively increase solute-free water excretion by the kidneys (aquaresis). In this review we explore the limitations of the current treatment of SIADH and describe emerging therapies for the treatment of SIADH-induced hyponatraemia.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center